To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions

NCT00913848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Bipolar Disorder

Interventions

DRUG: Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)
DRUG: Depakote 500 mg DR Tablets (Abbott Laboratories, USA)

Sponsor

Sandoz